


















httpComparative methods for handling missing data in
large databases
Antonia J. Henry, MD, MPH,a,b Nathanael D. Hevelone, MPH,b Stuart Lipsitz, ScD,b and
Louis L. Nguyen, MD, MBA, MPH,a,b Boston, Mass
Objective: Analysis of complex survey databases is an important tool for health services researchers. Missing data elements
are challenging because the reasons for “missingness” are multifactorial, especially categorical variables such as race. We
simulated missing data for race and analyzed the bias from ﬁve methods used in predicting major amputation in patients
with critical limb ischemia (CLI).
Methods: Patient discharges with fully observed data containing lower extremity revascularization or major amputation
and CLI were selected from the 2003 to 2007 Nationwide Inpatient Sample, a complex survey database (weighted n [
684,057). Considering several random missing data schemes, we compared ﬁve missing data methods: complete case
analysis, replacement with observed frequencies, missing indicator variable, multiple imputation, and reweighted esti-
mating equations. We created 100 simulated data sets, with 5%, 15%, or 30% of subjects’ race drawn to be missing from
the full data set. Bias was estimated by comparing the estimated regression coefﬁcients averaged over 100 simulated data
sets (bmiss) from each method vs estimates from the fully observed data set (bfull), with relative bias calculated as (bfull e
bmiss/bfull) 3 100%.
Results: Our results demonstrate that reweighted estimating equations produce the least biased and the missing indicator
variable produces the most biased coefﬁcients. Complete case analysis, replacement with observed frequencies, and
multiple imputation resulted in moderate bias. Sensitivity analysis demonstrated the optimal method choice depends on
the quantity and type of missing data encountered.
Conclusions: Missing data are an important analytic topic in research with large databases. The commonly used missing
indicator variable method introduces severe bias and should be used with caution. We present empiric evidence to guide
method selection for handling missing data. (J Vasc Surg 2013;58:1353-9.)Analysis of administrative databases is an important
tool for health services researchers in vascular surgery.
Large numbers and complex survey sampling methodology
offer opportunities to address clinical questions with
nationally representative data. Although diagnosis and
procedure codes are audited and algorithms enrich clinical
detail, missing data must be addressed by end-users.
Missing demographic data are problematic because reasons
for “missingness” are multifactorial. Critically ill patients
and certain demographic groups may be less likely to report
this information at hospital registration.1 Analytic methods
for handling missing data, especially categorical variables,
may introduce bias if the methods do not account forthe Division of Vascular & Endovascular Surgerya and the Center
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data for race and analyzed the bias from ﬁve missing
data methods to predict major amputation in patients
with critical limb ischemia (CLI). These methods may
not be necessary for all research with large databases, but
several post hoc methods for handling missing data will
be illustrated here.
Missing data mechanisms are deﬁned as missing
completely at random (MCAR), missing at random
(MAR), and not missing at random (NMAR). Under the
MCAR mechanism, the probability of missingness is unre-
lated to the unknown value of the variable or to other vari-
ables in the dataset.2-4 MAR assumes that the probability
that data are missing is not related to the unknown value
of the variable but is related to other variables. If the prob-
ability that data are missing is related to the unknown value
of the variable, then the data are NMAR. The missing data
mechanism must be modeled to obtain valid parameter
estimates, and this requires detailed a priori knowledge of
the missing data mechanism that is not usually available
to end-users.2 To focus on biases that can occur even
under MCAR and MAR, we will not simulate data that
are NMAR.
There are four common methods and one novel
method for handling missing data in large databases. These
include complete case analysis (CCA), replacement with
observed frequencies (RF), the missing indicator variable
method (MIV), multiple imputation (MI), and reweighted
estimating equations (RWEE). CCA deletes records with
any missing values and is the default in most software1353
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frequencies or means for the variable of interest calculated
from complete cases. In MIV, records with missing data on
multilevel categorical variables are designated with indi-
cator variables.
MI was designed to address missing data in complex
survey data sets where the database constructor and end-
users are distinct entities and there is no singular deﬁned
missing data mechanism.6 The missing values are imputed
based on a model relating the missing variable to observed
variables, generating multiple completed data sets. The
multiple parameter estimates and standard errors are
analyzed separately and combined to produce a single
parameter estimate and standard error representing the
uncertainty of the imputation process.4-6
RWEE is a novel method developed speciﬁcally for
complex survey data.7-9 The survey “weights” are the
inverse of the probability that a person was drawn from
the population to be sampled. RWEE adjusts the survey
weights of persons with completely observed data. The
original survey weights are multiplied by the inverse of
the probability that a person was drawn from the survey
to be a “complete case.” A logistic regression model esti-
mates the probability that the variable of interest is
observed and includes variables that are completely
observed and related to the variable of interest. The orig-
inal survey weights are multiplied by the inverse of the esti-
mated probability that the variable is observed. Records
with missing data are deleted, and the usual complex survey
analysis incorporating stratiﬁcation, clustering, and weight-
ing is performed with the new adjusted weights.
Health services researchers may ﬁnd that these
methods are applicable to work with large databases.
Correlating the missing data mechanism to the assump-
tions required by each method will guide selection of an
appropriate method. Using simulated data sets, we aim to
provide practical examples of the advantages and disadvan-
tages of ﬁve methods of handling missing data.
METHODS
Creation of the fully observed data set. The 2003 to
2007 Nationwide Inpatient Samples (NISs) were queried
for adult discharges containing a diagnosis of chronic
CLI and lower extremity revascularization (LER) or major
amputation.10 A weighted sum of 958,120 discharge
records was included in this initial cohort. Subject inclusion
and exclusion criteria have been reported elsewhere.9
Brieﬂy, patient discharges were selected if their record
contained International Classiﬁcation of Diseases-9th
Edition-Clinical Modiﬁcation codes for chronic CLI and
a procedure to treat CLI, including major lower extremity
amputation or LER (lower extremity bypass or angio-
plasty). The primary outcome was major amputation vs
LER. Records with missing data were excluded. The fully
observed data set included a weighted sum of 684,057
records.
As in our prior work, bivariate and multivariate logistic
regression were performed in the fully observed data set toexamine relationships between socioeconomic status,
comorbidities, hospital-level factors, and the outcome of
major amputation.9 To use a more parsimonious multivar-
iate model, we excluded several comorbidity variables from
our original work that were weakly associated with the
outcome and not signiﬁcant confounders of the primary
predictors, which were pulmonary circulatory disorders,
chronic pulmonary disease, uncomplicated diabetes, hypo-
thyroidism, liver disease, metastatic cancer, coagulopathy,
chronic blood loss anemia, drug abuse, psychoses, and
depression.
Missing data mechanism simulation. Race was simu-
lated to be missing for 5%, 15%, and 30% of the records in
the fully observed data set according to the MCAR and
MAR mechanisms. To estimate the potential bias intro-
duced by each method, 100 simulated data sets were
created for each scenario. To simulate MCAR, a random
number generator was used to delete the value for race
in 5%, 15%, and 30% of records.
To simulate missingness under MAR, multivariate
weighted logistic regression in the initial data set identiﬁed
predictors of missing race. These predictors included
metropolitan residential area type, hospital bed size,
hospital region, and several Agency for Healthcare
Research and Quality comorbidities (deﬁciency anemia,
complicated diabetes mellitus, obesity, and cardiac valvular
disease). Although the primary outcome of major amputa-
tion was not signiﬁcantly associated with missing values for
race, this variable was empirically included in the model to
satisfy the condition that missing data on the variable of
interest be associated with the outcome. Parameter esti-
mates from this regression model determined the proba-
bility for deleting race in the simulations. Predictors of
missing race were included in the multivariate logistic
regression model for the outcome of major amputation
to produce unbiased parameter estimates. To specify the
percentage of records with race deleted, the intercept for
the regression model was adjusted.
Analytic methods. Five missing data methods were
used to ﬁnd predictors of major amputation in each simu-
lation scenario using the same weighted multivariate
logistic regression model for the outcome of major ampu-
tation. The estimated regression coefﬁcients from the fully
observed data set were set as reference values. Estimated
regression coefﬁcients from the various missing data
methods were compared with these reference values to esti-
mate the bias of each missing data method.
CCA excluded all records with missing values on race
in the simulated data sets. For RF, six continuous variables
were created for race. For complete cases, the variable for
a race category was set to 1 based on the NIS value for
race and 0 in the other categories. The race variables for
all records where race had been deleted were ﬁlled in
with the group frequencies from the fully observed data
set, which were: white, 0.701; black, 0.165; Hispanic,
0.089; Asian/Paciﬁc Islander, 0.012; Native American,
0.006; and other race, 0.019. Records with missing data
on race were treated as having a probability of representing
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ables for each level of race were created in addition to
a seventh variable for records with missing data on race.
For MI, ﬁve replacement data sets were created for
each simulation, and the missing values for race were
imputed using the multinomial logistic regression imputa-
tion model for monotone missing data in SAS 9.2 software
(SAS Institute, Cary, NC), which ﬁt a different probability
of being in each race group.11,12 SAS PROC MI does
not incorporate survey weights into the imputation
procedure. Each data set was analyzed separately. The
parameter estimates and standard errors were combined
in the SAS MIANALYZE procedure to output parameter
estimates for each level of race with white as the reference
group.11,12
In RWEE, a weighted logistic regression model was
run in the simulated data sets to estimate parameters
for the outcome that race was observed given three vari-
ables that were observed for all records in the fully
observed data set: median income quartile, hospital
region, and discharge year. Records with race observed
were included in the analysis using the RWEE-adjusted
survey weights.
Statistical analysis. The estimated regression coefﬁ-
cients from the multivariate model were averaged across
100 simulated data sets under the six scenarios of
MCAR, 5%, 15%, and 30% missing; and MAR, 5%, 15%,
and 30% missing. To determine the amount of bias in
the regression coefﬁcients from each missing data method,
we compared the average of the estimated regression coef-
ﬁcients (bmiss) to the reference values from the fully
observed data set (bfull). The percentage difference
between the mean of the estimated coefﬁcients from the
simulated data sets and the coefﬁcients from the fully
observed data set was deﬁned as the estimated relative
bias and calculated as (bfull e bmiss/bfull)  100%. The
magnitude of the relative bias was graded for clearer inter-
pretation based on expert consultation with our group’s
statistician. The grades are deﬁned as negligible (0%-5%),
minimal (5%-10%), moderate (10%-20%), heavy (20%-
30%), and severe (>30%). Student’s t-test was used
to determine if the means of the estimated regression
coefﬁcients were signiﬁcantly different from the reference
coefﬁcients estimated from the fully observed data set. To
account for multiple testing, we set the criterion for signif-
icance at a < .001. All database linkages and analyses were
performed with SAS 9.2 software.
RESULTS
CCA produced minimally biased regression coefﬁ-
cients in the MCAR scenarios. Data from the 5% and
15% missing scenarios are presented in the Supplementary
Tables I-VI (online only) due to similar results between
MCAR and MAR. CCA performed well in the MCAR
scenarios where few mean regression coefﬁcients were
minimally to moderately biased (Table I; Supplementary
Tables I-III, online only). In the MAR scenarios, CCA
performed less favorably because many of the estimatedcoefﬁcients had moderate to severe bias (Table II;
Supplementary Tables IV-VI, online only). With
increasing missingness, the estimated coefﬁcients were
more likely to have heavy to severe relative bias.
RF resulted in many estimated coefﬁcients that were
moderately to severely biased. In the MCAR-5% missing
scenario, three estimated coefﬁcients were heavily to
severely biased, and this number increased in the 15%
and 30% missing scenarios. In the MAR scenarios, heavy
to severe bias was found frequently. RF performed less
favorably than CCA across all scenarios.
MIV introduced the most bias compared with the
other four methods. Most of the estimated coefﬁcients
had heavy to severe relative bias across all scenarios. In
the MCAR-5% missing scenario, >75% of the estimated
coefﬁcients were severely biased. This method continued
to perform poorly as the percentage of missing data
increased and under MAR.
The results of the MI method were more biased than
those from CCA or RWEE. In the MCAR-5% missing
scenario, six mean regression coefﬁcients carried moderate
to heavy relative bias. The relative bias increased along with
the percentage missing and under MAR. In the MAR-30%
missing scenario, nine estimated coefﬁcients carried heavy
to severe relative bias, and >90% of the estimated coefﬁ-
cients were signiﬁcantly different from the reference
coefﬁcients.
RWEE produced the least biased parameter estimates
across all scenarios. In the MCAR scenarios, this method
performed similarly to CCA. In the MAR scenarios,
RWEE surpassed CCA in producing the least biased
results. Under the most challenging scenario, MAR-30%
missing, only three estimated regression coefﬁcients were
moderately to severely biased.
Income quartile and hospital region were highly sensi-
tive to the amount of missing data, the missing data mech-
anism, and the analytic method. The relative bias for the
income variable levels increased twofold when the
percentage of missing data increased from 15% to 30% in
the MCAR and MAR scenarios when RF or MI was
used. RWEE included this variable in the reweighting
process, potentially contributing to minimal relative bias.
In the MAR scenarios, the probability of missing race
was based on several predictors, including region. In the
30% missing data scenarios, the relative bias for region
introduced by CCA increased from 0.05% to 1.6% under
MCAR to 25.7% to 1103.3% under MAR. Again, the
inclusion of hospital region in the RWEE model resulted
in a more modest increase in the range of relative bias,
3% to 37%.
Table III summarizes the results across the different
simulation scenarios by converting the results into a linear
score and grading system. The relative bias categories were
assigned a 5-point scale, from 5 for negligible to 1 for
severe. The percentages of variables in each relative bias
category were multiplied by the point value. The sum of
these scores for each simulation scenario ranged from
100 to 500. A score of 100 to 149 was designated as
Table I. Missing completely at random: 30% missing
Variable
Relative biasa
CCA RF MIV MI RWEE
Age, years
Q2: 62-70 0.29 1.36b 1.37b 2.24b 0.29
Q3: 71-78 0.50 6.42b 6.41b 6.70b 0.49
Q4: >78 0.04 18.75b 18.67b 14.38b 0.05
Race
Black 0.04 6.55b 6.07b 16.24b 0.05
Hispanic 0.34 10.29b 9.62b 6.40b 0.34
Asian/PI 1.46 4.49 3.89 41.66b 1.46
Native American 0.28 5.30b 4.99b 1.82 0.29
Other 1.47 11.59b 11.10b 104.83b 1.48
Female sex 0.45 8.61b 215.28b 7.66b 0.44
Income
Q1 1.48 48.33b 191.55b 24.73b 1.49
Q2 1.43 28.66b 118.42b 14.60b 1.43
Q3 5.12 54.11b 403.97b 25.92b 5.17
Insurance
Private 0.65 4.40b 116.11b 3.21b 0.66
Medicaid 1.57 8.21b 252.38b 4.26b 1.54
Uninsured 10.06 4.23b 610.09b 47.93b 10.24
Small metropolitan 0.57 24.45b 80.68b 14.12b 0.56
Micropolitan 4.46 133.55b 158.65b 62.27b 4.41
Nonmetropolitan 9.80 630.19b 231.92b 328.23b 9.82
Congestive heart failure 0.02 0.58b 105.80b 0.16b 0.03
Cardiac valve disease 0.18 4.27b 286.19b 2.01b 0.18
Complicated diabetes 0.23 0.82b 65.68b 0.69b 0.23
Hypertension 0.15 5.66b 383.93b 3.35b 0.16
Electrolyte disorders 0.35 0.14b 152.16b 0.06 0.35
Neurologic disorder 0.21 1.71b 32.04b 1.57b 0.20
Paralysis 0.03 1.47b 21.46b 1.06b 0.03
Vascular disease 0.05 1.07b 21.48b 1.02b 0.04
Renal failure 0.93 14.85b 533.67b 6.23b 0.93
Weight loss 0.00 0.77b 77.46b 0.49b 0.01
Obesity 0.43 5.50b 474.78b 2.16b 0.44
Deﬁciency anemia 0.35 2.68b 154.79b 1.64b 0.36
Diagnostic angiogram 0.05 0.19b 124.25b 0.06b 0.05
Elective 0.09 1.18b 373.33b 0.84b 0.09
LER volume/y
Q1: 0-11 0.25 0.51b 71.72b 0.04 0.25
Q2: 12-71 0.08 0.94b 169.11b 0.35b 0.08
Q3: 72-248 0.25 2.05b 90.09b 0.99b 0.25
Hospital size
Small 0.88 0.65b 282.13b 0.54b 0.89
Medium 1.42 0.55b 154.33b 1.82b 1.44
Midwest 0.05 111.21b 1553.02b 101.16b 0.54
South 0.62 10.92b 108.66b 9.04b 0.62
West 1.59 8.09b 289.80b 66.48b 1.58
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRelative bias: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
bP < .001.
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350 to 449 as four stars, and 450 to 500 as ﬁve stars.
DISCUSSION
Most databases have some missing data, and categori-
cal variables with missing data add another layer of difﬁ-
culty. Many researchers simplify the handling of missing
data and risk, introducing bias. Our evaluation of four
common and one novel method for handling missingdata may serve as a useful guide for other researchers.
The results of the simulations demonstrated that
MCAR, CCA, and RWEE perform well, introducing the
least amount of bias, followed by RF and MI, and lastly,
MIV. When applied to data that are MAR, RWEE
resulted in less biased parameter estimates than other
methods. MIV produced the most severely biased results
across all scenarios. The bias we observed when we used
MIV, RF, and MI was found in other predictor variables
Table II. Missing at random: 30% missing
Variable
Relative biasa
CCA RF MIV MI RWEE
Age, years
Q2: 62-70 2.12b 1.52b 1.41b 2.11b 1.28
Q3: 71-78 5.07b 7.51b 7.21b 7.16b 0.77
Q4: >78 9.24b 20.81b 19.59b 14.55b 4.31
Race
Black 1.56b 14.87b 9.33b 19.88b 0.14
Hispanic 0.99 18.86b 13.82b 2.16b 0.15
Asian/PI 0.72 6.18b 7.31b 40.59b 1.70
Native American 2.99 13.76b 8.99b 5.01b 0.53
Other 11.56b 24.81b 22.73b 92.72b 3.12
Female sex 0.47 9.72b 468.24b 7.89b 0.41
Income
Q1 4.89b 54.06b 191.06b 29.69b 0.11
Q2 2.02 26.30b 122.96b 15.53b 0.43
Q3 19.74b 41.92b 387.23b 25.27b 6.72
Insurance
Private 1.95b 5.06b 114.37b 3.59b 0.14
Medicaid 7.98b 9.03b 253.09b 4.08b 0.07
Uninsured 14.98 1.91 610.37b 52.01b 5.47
Small metropolitan 46.33b 25.84b 80.38b 16.60b 0.39
Micropolitan 136.88b 151.58b 1.76 71.04b 2.88
Nonmetropolitan 378.96b 752.32b 915.44b 422.77b 44.32
Congestive heart failure 2.63b 0.65b 112.40b 0.20b 0.01
Cardiac valve disease 2.51 5.01b 286.19b 2.66b 0.35
Complicated diabetes 2.25b 0.70b 62.63b 0.76b 0.26
Hypertension 3.26b 6.80b 388.54b 4.08b 0.65
Electrolyte disorders 0.11 0.17b 151.81b 0.03 0.00
Neurologic disorder 2.55b 2.15b 32.04b 1.94b 0.44
Paralysis 2.49b 1.65b 21.26b 1.10b 0.38
Vascular disease 4.00b 1.28b 221.46b 1.08b 0.02
Renal failure 11.64b 17.59b 534.45b 7.90b 0.79
Weight loss 2.19b 1.13b 77.02b 0.73b 0.06
Obesity 14.75b 6.71b 475.23b 2.59b 1.41
Deﬁciency anemia 2.55b 2.86b 148.43b 1.96b 0.15
Diagnostic angiogram 0.89b 0.16b 125.15b 0.01 0.13
Elective 0.31 1.19b 372.74b 0.81b 0.03
LER volume/y
Q1: 0-11 2.43b 0.50b 71.77b 0.01 0.14
Q2: 12-71 1.41b 1.08b 169.39b 0.14b 0.42
Q3: 72-248 0.84b 2.05b 90.03b 1.12b 0.52
Small hospital 20.35b 1.63b 281.88b 0.79b 0.15
Medium hospital 52.97b 4.94b 104.88b 1.08b 0.34
Midwest 1103.13b 165.59b 676.05b 118.39b 17.50
South 25.81b 15.78b 164.26b 12.77b 3.02b
West 25.70b 6.54b 258.14b 54.16b 37.14b
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRelative bias: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
bP < .001.
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socioeconomic status.
Understanding the data source and database structure
is a ﬁrst step. We drew a cohort from the NIS, which repre-
sents a 20% stratiﬁed probability sample of United States
community hospitals. The reasons for data to be missing
in the NIS depend on the type of variable, data collection,
and recoding of sensitive demographic and disease-related
information to prevent subject identiﬁcation. The 2007
NIS contains data from 40 participating states, 10 of whichdo not report data for race.10 Of the 25% of discharges with
missing data on race, 20% are from states that do not report
this information. In these cases, missingness is clustered by
state and unrelated to the intrinsic characteristics of the
patients. The other 5% are missing for unknown reasons.
Given the differences in state reporting patterns in the
NIS, the missing data mechanism for race was assumed
to meet criteria for MAR rather than NMAR. In addition,
a logistic regression model for the outcome of missingness
can be used to determine if the data are MCAR vs MAR.
Table III. Summary of results of linear scoring for
relative bias from each method
Variable CCA RF MIV MI RWEE
MCAR missing
5% 5+ 5+ 2+ 5+ 5+
15% 5+ 4+ 2+ 4+ 5+
30% 5+ 4+ 2+ 4+ 5+
MAR missing
5% 5+ 5+ 2+ 5+ 5+
15% 4+ 4+ 2+ 4+ 5+
30% 4+ 4+ 2+ 4+ 5+
CCA, Complete case analysis; MAR, missing at random; MCAR, missing
completely at random; MI, multiple imputation; MIV, missing indicator
variable; RF, replacement with observed frequencies; RWEE, reweighted
estimating equations.
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associated with the outcome of missingness, the data may
be MCAR. If not, the data may be MAR, and RWEE
may be applicable.
If the missing data mechanism can be determined,
researchers must choose a post hoc method that incorpo-
rates the missing data into the analysis. We tested four
common and one novel method in six simulation scenarios
that may be encountered by end-users of large databases.
Under MCAR, CCA produced regression coefﬁcients
with minimal relative bias that were not signiﬁcantly
different from reference coefﬁcients. These ﬁndings
conﬁrmed that CCA will produce unbiased inferences
if the data are MCAR. In the MAR scenarios, CCA intro-
duced less bias than MI. One important disadvantage of
CCA is the reduction in statistical power caused by
excluding individuals with missing values for some
variables.3,4
RF and MIV are attractive options for many researchers
because both allow for conservation of sample size.
However, there are several important disadvantages. First,
neither method incorporates the survey sampling design.
Second, replacing the missing values with the mean
frequencies or assigning an indicator variable for missing
data assumes homogeneity of the records with missing
values and ignores associations between variables, intro-
ducing greater bias. Furthermore, RF fails to account for
the uncertainty of the replaced value and underestimates
the standard errors.6 In our analysis, most of the estimated
regression coefﬁcients in MIV were signiﬁcantly different
from the reference values. MIV introduced the most severe
bias into the results in all simulation scenarios and should
be used with great caution.
MI introduced more bias into the estimated coefﬁ-
cients than expected. One potential explanation is that
the MI procedure we used does not incorporate survey
weights into the imputation procedure, leading to bias.
In another simulation of imputation of categorical variables
with PROC MI, Allison5 found that CCA and logistic
imputation performed equally well and introduced similar
degrees of bias into the analysis. In the simulationspresented there, sensitivity analyses were not performed
with increasing amounts of missingness, as we did. In
a study of patients receiving cancer care, CCA, MIV, and
MI were compared in identifying predictors of having
a discussion about hospice care. Most variables had some
missing data and were MAR or NMAR. The author deter-
mined that CCA deleted records in a nonrandom fashion,
leading to biased parameter estimates and standard errors
and, ultimately, to misidentiﬁcation of signiﬁcant predic-
tors of the outcome. That analysis found the results of
MIV were similar to those from MI.4
RWEE provided the least biased results across all
scenarios and also incorporated the complex survey design
into the analysis step where missing data are handled. In
the MAR scenarios, RWEE introduced the least bias into
the estimated regression coefﬁcients. RWEE remained
robust to increasing amounts of missingness. Although
this method is a ﬂexible option for analysts, it is easiest to
implement when only one variable has missing values. A
solution has been suggested for applying weighted esti-
mating equations to data sets with more complicated
patterns of missing data.13,14 If multiple variables have
missing data, but there are enough fully observed variables
in the data set that are associated with the probability of
having missing data to develop a good predictive model
for being a complete case, then RWEE will give unbiased
estimates.
This work has several important limitations. First, our
reference data set represents a complete case analysis of
the original data set where we assumed most of the records
with missing race were MAR due to state reporting prac-
tices. We acknowledge that end-users of large databases
are unable to determine if the missing data mechanism is
MAR or NMAR. This assumption potentially carried bias
into the simulated data sets.
Second, in our MAR simulations, we deleted race
based on associations that were present in the initial data
set. The estimated coefﬁcients for the associations between
predictors and the outcome of amputation may have been
biased using this approach. However, we assert that
applying these associations from the initial data set to the
simulated data sets may be more realistic and less biased
than those drawn from a different database. By using the
best available real data, our simulations represent a realistic
situation that would be encountered by health services
researchers in vascular surgery.
Third, we limited our simulation to one categorical
variable with missing values given the challenges presented
to researchers. The application of these methods to binary
or continuous variables will produce similar results.8
CONCLUSIONS
These limitations notwithstanding, the simulation
scenarios presented here are unique in that we modeled
plausible situations that end-users of large databases
encounter and present evidence to support selection of
the most appropriate method to handle missing data.
This work is novel because we used real data as the basis
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complex survey database. These ﬁve methods for handling
missing data can be applied to nonsample survey databases
with similar results. RWEE was initially developed for non-
survey-weighted data as an extension of nonresponse
weighting.13 In nonsample surveys, each record has
a weight of 1.
Missing data is an important analytical topic in health
outcomes research because most databases have some
missing data and mishandling the data can introduce bias.
When the amount of missing data is small and the mecha-
nism is MCAR, CCA and RWEE perform well. If the
percentage of records with missing values approaches 30%
or if the data are MAR, we recommend RWEE. MI may
produce biased results if the multiple imputation procedure
does not incorporate survey weights.
These methods may not be necessary for all research
with large databases, but if they are, we offer recommenda-
tions based on an empiric simulation to assist others in
making an informed decision about handling missing
data. If the variables of interest are critical to the analysis
and associated with the outcome and a substantial propor-
tion of records are incomplete, then one of these post hoc
methods may be applicable. Method selection should be
guided by the proportion of missing data, the missing
data mechanism, and the relationship of the variable to
the outcome. RWEE is a novel and ﬂexible option that
provides less biased parameter estimates. Because of its
simplicity of implementation, MIV may be the most widely
used approach; however, MIV introduced the most bias
and should be used with caution. These simulation
scenarios may serve as a useful guide for other users of
complex survey databases.
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Supplementary Table I (online only). Missing completely at random: 5% missing
Variable
CCA RF MIV MI RWEE
RBa SE P RB SE P RB SE P RB SE P RB SE P
Age, years
Q2: 62-70 0.28 0.16 .080 0.25 0.02 <.0001 0.25 0.02 .0001 0.48 0.02 <.0001 0.28 0.16 .078
Q3: 71-78 0.58 0.20 .004 1.08 0.03 <.0001 1.08 0.03 <.0001 1.30 0.03 <.0001 0.58 0.20 .004
Q4: >78 0.50 0.46 .282 3.23 0.07 <.0001 3.20 0.07 <.0001 2.78 0.07 <.0001 0.50 0.46 .279
Race
Black 0.10 0.06 .090 1.05 0.06 <.0001 0.97 0.06 <.0001 2.74 0.06 <.0001 0.10 0.06 .095
Hispanic 0.02 0.12 .897 1.87 0.13 <.0001 1.75 0.13 <.0001 1.10 0.14 <.0001 0.01 0.12 .910
Asian/PI 0.74 0.50 .144 0.38 0.50 .443 0.28 0.50 .576 8.56 0.51 <.0001 0.73 0.50 .146
Native American 0.30 0.35 .390 0.56 0.35 .117 0.50 0.35 .156 0.85 0.36 .021 0.30 0.35 .395
Other 0.71 0.74 .338 1.11 0.74 .135 1.02 0.74 .168 19.61 0.77 <.0001 0.71 0.74 .341
Female sex 0.24 0.20 .240 1.48 0.03 <.0001 220.41 1.79 <.0001 1.46 0.03 <.0001 0.23 0.20 .245
Income
Q1 0.29 0.29 .315 8.44 0.09 <.0001 198.65 0.03 <.0001 4.66 0.09 <.0001 0.29 0.29 .323
Q2 0.99 0.48 .043 5.00 0.07 <.0001 59.89 0.13 <.0001 2.70 0.07 <.0001 0.99 0.48 .044
Q3 0.95 1.66 .568 9.17 0.24 <.0001 311.61 0.28 <.0001 4.46 0.25 <.0001 0.94 1.66 .572
Insurance
Private 0.25 0.17 .145 0.76 0.03 <.0001 111.42 0.03 <.0001 0.59 0.03 <.0001 0.25 0.17 .144
Medicaid 0.65 0.34 .059 1.47 0.06 <.0001 247.08 0.04 <.0001 0.84 0.06 <.0001 0.65 0.34 .057
Uninsured 0.32 2.79 .908 0.81 0.48 .093 566.24 0.40 <.0001 10.15 0.49 <.0001 0.31 2.79 .911
Small metropolitan 0.25 0.24 .295 4.27 0.06 <.0001 81.30 0.09 <.0001 2.59 0.05 <.0001 0.26 0.24 .292
Micropolitan 1.25 1.19 .299 23.28 0.30 <.0001 227.20 0.20 <.0001 11.46 0.29 <.0001 1.24 1.20 .302
Nonmetropolitan 5.34 5.42 .326 111.46 1.35 <.0001 208.94 1.22 <.0001 62.46 1.27 <.0001 5.23 5.41 .336
Congestive heart
failure
0.02 0.04 .699 0.10 0.01 <.0001 100.12 0.01 <.0001 0.02 0.01 .001 0.02 0.04 .675
Cardiac valve disease 0.07 0.28 .810 0.83 0.03 <.0001 288.04 0.02 <.0001 0.42 0.03 <.0001 0.07 0.28 .801
Complicated
diabetes
0.04 0.05 .463 0.15 0.01 <.0001 64.46 0.01 <.0001 0.13 0.01 <.0001 0.04 0.05 .465
Hypertension 0.09 0.13 .471 1.00 0.02 <.0001 382.03 0.02 <.0001 0.67 0.02 <.0001 0.09 0.13 .474
Electrolyte disorders 0.04 0.09 .624 0.03 0.01 .030 154.71 0.01 <.0001 0.01 0.01 .696 0.04 0.09 .637
Neurologic disorder 0.09 0.09 .330 0.30 0.01 <.0001 32.11 0.01 <.0001 0.32 0.01 <.0001 0.08 0.09 .340
Paralysis 0.05 0.10 .605 0.29 0.01 <.0001 22.54 0.01 <.0001 0.24 0.01 <.0001 0.06 0.10 .595
Vascular disease 0.07 0.04 .076 0.19 0.01 <.0001 220.07 0.02 <.0001 0.21 0.01 <.0001 0.07 0.04 .074
Renal failure 0.39 0.22 .078 2.62 0.04 <.0001 529.88 0.02 <.0001 1.22 0.04 <.0001 0.39 0.22 .081
Weight loss 0.10 0.08 .251 0.14 0.01 <.0001 79.85 0.01 <.0001 0.09 0.01 <.0001 0.10 0.08 .252
Obesity 0.54 0.34 .113 0.99 0.04 <.0001 472.42 0.05 <.0001 0.41 0.04 <.0001 0.54 0.34 .113
Deﬁciency anemia 0.00 0.08 .970 0.48 0.01 <.0001 152.46 0.02 <.0001 0.32 0.01 <.0001 0.01 0.08 .941
Diagnostic
angiogram
0.02 0.03 .370 0.03 0.00 <.0001 123.73 0.00 <.0001 0.01 0.00 .001 0.02 0.03 .362
Elective 0.06 0.04 .152 0.21 0.01 <.0001 373.77 0.01 <.0001 0.17 0.01 <.0001 0.06 0.04 .153
LER volume/y
Q1: 0-11 0.04 0.05 .436 0.09 0.01 <.0001 71.99 0.00 <.0001 0.01 0.01 .096 0.04 0.05 .443
Q2: 12-71 0.01 0.06 .834 0.16 0.01 <.0001 167.98 0.02 <.0001 0.08 0.01 <.0001 0.01 0.06 .824
Q3: 72-248 0.04 0.08 .601 0.36 0.01 <.0001 88.62 0.02 <.0001 0.17 0.01 <.0001 0.04 0.08 .620
Small hospital 0.12 0.19 .539 0.16 0.02 <.0001 279.13 0.02 <.0001 0.14 0.03 <.0001 0.12 0.19 .533
Medium hospital 0.34 0.34 .312 0.08 0.05 .113 153.11 0.06 <.0001 0.33 0.05 <.0001 0.34 0.34 .313
Midwest 5.12 6.64 .442 20.69 1.19 <.0001 1560.90 0.80 <.0001 18.75 1.20 <.0001 5.06 6.65 .448
South 0.00 0.22 .986 1.91 0.04 <.0001 104.95 0.05 <.0001 1.65 0.04 <.0001 0.01 0.22 .979
West 0.26 1.08 .811 1.56 0.25 <.0001 258.29 0.16 <.0001 14.06 0.27 <.0001 0.28 1.08 .795
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RB, relative bias; SE, standard error; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRB: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
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Supplementary Table II (online only). Missing completely at random: 15% missing
Variable
CCA RF MIV MI RWEE
RBa SE P RBa SE P RBa SE P RBa SE P RBa SE P
Age, years
Q2: 62-70 0.61 0.31 .051 0.68 0.03 <.0001 0.67 0.03 <.0001 1.25 0.04 <.0001 0.61 0.31 .049
Q3: 71-78 0.43 0.36 .241 3.20 0.05 <.0001 3.18 0.05 <.0001 3.60 0.06 <.0001 0.44 0.36 .224
Q4: >78 0.15 0.83 .856 9.43 0.11 <.0001 9.35 0.11 <.0001 7.73 0.12 <.0001 0.18 0.83 .829
Race
Black 0.12 0.09 .186 3.26 0.10 <.0001 3.01 0.09 <.0001 8.15 0.08 <.0001 0.12 0.09 .193
Hispanic 0.00 0.24 .996 5.60 0.26 <.0001 5.24 0.26 <.0001 2.87 0.24 <.0001 0.00 0.24 .991
Asian/PI 1.98 0.87 .025 5.49 0.87 <.0001 5.18 0.87 <.0001 18.99 0.74 <.0001 2.00 0.87 .024
Native American 0.16 0.50 .750 2.49 0.51 <.0001 2.32 0.51 <.0001 1.31 0.49 .010 0.16 0.50 .753
Other 0.81 1.22 .508 6.22 1.23 <.0001 5.95 1.23 <.0001 54.78 1.33 <.0001 0.83 1.22 .499
Female sex 0.22 0.30 .468 4.46 0.05 <.0001 218.79 1.06 <.0001 4.24 0.05 <.0001 0.22 0.30 .458
Income
Q1 0.27 0.49 .579 24.93 0.15 <.0001 195.68 0.05 <.0001 13.34 0.16 <.0001 0.27 0.49 .586
Q2 1.12 0.77 .147 14.81 0.12 <.0001 84.06 0.23 <.0001 7.91 0.14 <.0001 1.12 0.77 .147
Q3 1.24 3.34 .712 27.59 0.38 <.0001 349.96 0.48 <.0001 13.63 0.43 <.0001 1.24 3.34 .710
Insurance
Private 0.06 0.32 .843 2.14 0.04 <.0001 113.35 0.04 <.0001 1.66 0.04 <.0001 0.07 0.32 .832
Medicaid 0.48 0.62 .436 4.41 0.10 <.0001 249.08 0.06 <.0001 2.15 0.11 <.0001 0.47 0.62 .448
Uninsured 2.32 5.50 .674 3.17 0.66 <.0001 585.39 0.63 <.0001 26.31 0.74 <.0001 2.28 5.50 .680
Small metropolitan 0.30 0.40 .459 12.57 0.08 <.0001 80.85 0.12 <.0001 7.51 0.09 <.0001 0.28 0.40 .482
Micropolitan 1.41 1.97 .475 68.83 0.45 <.0001 199.05 0.29 <.0001 33.14 0.43 <.0001 1.44 1.98 .469
Nonmetropolitan 15.65 9.24 .093 327.93 2.11 <.0001 27.14 1.79 <.0001 180.13 2.15 <.0001 15.48 9.24 .097
Congestive heart
failure
0.01 0.08 .928 0.30 0.01 <.0001 102.49 0.02 <.0001 0.08 0.01 <.0001 0.01 0.08 .899
Cardiac valve
disease
0.29 0.50 .567 2.39 0.06 <.0001 287.29 0.04 <.0001 1.27 0.07 <.0001 0.28 0.50 .583
Complicated
diabetes
0.14 0.09 .132 0.45 0.01 <.0001 65.00 0.02 <.0001 0.38 0.01 <.0001 0.15 0.09 .110
Hypertension 0.11 0.22 .613 2.94 0.03 <.0001 382.86 0.04 <.0001 1.83 0.03 <.0001 0.10 0.22 .646
Electrolyte
disorders
0.02 0.16 .908 0.07 0.02 .001 153.65 0.02 <.0001 0.03 0.02 .137 0.03 0.16 .866
Neurologic
disorder
0.01 0.19 .959 0.89 0.02 <.0001 32.08 0.01 <.0001 0.90 0.02 <.0001 0.00 0.19 .991
Paralysis 0.20 0.16 .199 0.75 0.02 <.0001 22.09 0.02 <.0001 0.57 0.02 <.0001 0.19 0.16 .216
Vascular disease 0.05 0.07 .469 0.54 0.01 <.0001 220.62 0.03 <.0001 0.56 0.01 <.0001 0.05 0.07 .507
Renal failure 0.01 0.38 .983 7.79 0.06 <.0001 531.38 0.04 <.0001 3.57 0.07 <.0001 0.05 0.38 .886
Weight loss 0.03 0.15 .841 0.40 0.02 <.0001 78.84 0.01 <.0001 0.26 0.02 <.0001 0.03 0.15 .863
Obesity 0.34 0.57 .548 2.93 0.07 <.0001 473.40 0.08 <.0001 1.20 0.08 <.0001 0.33 0.57 .558
Deﬁciency anemia 0.07 0.15 .633 1.39 0.02 <.0001 153.46 0.04 <.0001 0.89 0.02 <.0001 0.07 0.15 .634
Diagnostic
angiogram
0.00 0.05 .970 0.10 0.01 <.0001 123.94 0.00 <.0001 0.02 0.00 <.0001 0.00 0.05 .945
Elective 0.03 0.09 .720 0.62 0.01 <.0001 373.58 0.01 <.0001 0.47 0.01 <.0001 0.03 0.09 .721
LER volume/y
Q1: 0-11 0.08 0.09 .339 0.27 0.01 <.0001 71.88 0.00 <.0001 0.00 0.01 .935 0.09 0.09 .325
Q2: 12-71 0.01 0.12 .942 0.47 0.02 <.0001 168.47 0.02 <.0001 0.19 0.02 <.0001 0.01 0.12 .941
Q3: 72-248 0.08 0.15 .605 1.04 0.02 <.0001 89.22 0.03 <.0001 0.51 0.02 <.0001 0.08 0.15 .606
Small hospital 0.40 0.36 .267 0.35 0.04 <.0001 280.34 0.04 <.0001 0.37 0.05 <.0001 0.38 0.36 .284
Medium hospital 0.17 0.61 .774 0.39 0.08 <.0001 153.56 0.11 <.0001 1.04 0.08 <.0001 0.16 0.60 .789
Midwest 9.26 14.17 .515 59.21 1.51 <.0001 1555.85 1.38 <.0001 57.53 1.68 <.0001 9.18 14.20 .520
South 0.15 0.44 .729 5.67 0.06 <.0001 106.53 0.06 <.0001 4.94 0.06 <.0001 0.14 0.44 .755
West 0.75 1.96 .702 5.88 0.44 <.0001 271.39 0.21 <.0001 36.36 0.43 <.0001 0.73 1.96 .712
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RB, relative bias; SE, standard error; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRB: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
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Supplementary Table III (online only). Missing completely at random: 30% missing
Variable
CCA RF MIV MI RWEE
RBa SE P RB SE P RBa SE P RBa SE P RBa SE P
Age, years
Q2: 62-70 0.29 0.46 .531 1.36 0.04 <.0001 1.37 0.04 <.0001 2.24 0.05 <.0001 0.29 0.46 .536
Q3: 71-78 0.50 0.58 .396 6.42 0.06 <.0001 6.41 0.06 <.0001 6.70 0.07 <.0001 0.49 0.58 .398
Q4: >78 0.04 1.01 .970 18.75 0.12 <.0001 18.67 0.12 <.0001 14.38 0.15 <.0001 0.05 1.01 .957
Race
Black 0.04 0.14 .762 6.55 0.15 <.0001 6.07 0.15 <.0001 16.24 0.13 <.0001 0.05 0.14 .722
Hispanic 0.34 0.37 .353 10.29 0.37 <.0001 9.62 0.37 <.0001 6.40 0.36 <.0001 0.34 0.37 .358
Asian/PI 1.46 1.42 .307 4.49 1.44 .002 3.89 1.44 .008 41.66 1.12 <.0001 1.46 1.42 .306
Native
American
0.28 0.98 .776 5.30 0.97 <.0001 4.99 0.97 <.0001 1.82 0.70 .011 0.29 0.98 .768
Other 1.47 2.12 .491 11.59 2.16 <.0001 11.10 2.17 <.0001 104.83 1.69 <.0001 1.48 2.12 .486
Female sex 0.45 0.58 .437 8.61 0.07 <.0001 215.28 0.86 <.0001 7.66 0.07 <.0001 0.44 0.57 .449
Income
Q1 1.48 0.79 .064 48.33 0.18 <.0001 191.55 0.07 <.0001 24.73 0.23 <.0001 1.49 0.79 .062
Q2 1.43 1.21 .238 28.66 0.15 <.0001 118.42 0.26 <.0001 14.60 0.19 <.0001 1.43 1.21 .239
Q3 5.12 4.95 .303 54.11 0.48 <.0001 403.97 0.58 <.0001 25.92 0.62 <.0001 5.17 4.95 .299
Insurance
Private 0.65 0.55 .240 4.40 0.05 <.0001 116.11 0.05 <.0001 3.21 0.06 <.0001 0.66 0.55 .231
Medicaid 1.57 1.10 .158 8.21 0.11 <.0001 252.38 0.07 <.0001 4.26 0.14 <.0001 1.54 1.10 .166
Uninsured 10.06 8.31 .229 4.23 1.08 <.001 610.09 0.70 <.0001 47.93 1.23 <.0001 10.24 8.30 .221
Small
metropolitan
0.57 0.71 .426 24.45 0.11 <.0001 80.68 0.20 <.0001 14.12 0.12 <.0001 0.56 0.71 .433
Micropolitan 4.46 3.12 .156 133.55 0.53 <.0001 158.65 0.38 <.0001 62.27 0.72 <.0001 4.41 3.13 .162
Nonmetropolitan 9.80 16.97 .565 630.19 2.73 <.0001 231.92 2.11 <.0001 328.23 3.07 <.0001 9.82 16.97 .564
Congestive heart
failure
0.02 0.13 .889 0.58 0.01 <.0001 105.80 0.03 <.0001 0.16 0.02 <.0001 0.03 0.13 .801
Cardiac valve
disease
0.18 0.85 .834 4.27 0.07 <.0001 286.19 0.05 <.0001 2.01 0.09 <.0001 0.18 0.85 .835
Complicated
diabetes
0.23 0.17 .181 0.82 0.02 <.0001 65.68 0.03 <.0001 0.69 0.02 <.0001 0.23 0.17 .174
Hypertension 0.15 0.43 .720 5.66 0.04 <.0001 383.93 0.05 <.0001 3.35 0.04 <.0001 0.16 0.42 .710
Electrolyte
disorders
0.35 0.25 .170 0.14 0.02 <.0001 152.16 0.02 <.0001 0.06 0.03 .049 0.35 0.26 .172
Neurologic
disorder
0.21 0.28 .450 1.71 0.03 <.0001 32.04 0.02 <.0001 1.57 0.03 <.0001 0.20 0.28 .469
Paralysis 0.03 0.27 .905 1.47 0.03 <.0001 21.46 0.02 <.0001 1.06 0.04 <.0001 0.03 0.27 .922
Vascular disease 0.05 0.12 .675 1.07 0.01 <.0001 21.48 0.04 <.0001 1.02 0.01 <.0001 0.04 0.12 .748
Renal failure 0.93 0.64 .147 14.85 0.08 <.0001 533.67 0.05 <.0001 6.23 0.09 <.0001 0.93 0.63 .147
Weight loss 0.00 0.25 .997 0.77 0.02 <.0001 77.46 0.01 <.0001 0.49 0.03 <.0001 0.01 0.25 .974
Obesity 0.43 0.82 .600 5.50 0.09 <.0001 474.78 0.09 <.0001 2.16 0.09 <.0001 0.44 0.82 .592
Deﬁciency anemia 0.35 0.25 .153 2.68 0.03 <.0001 154.79 0.04 <.0001 1.64 0.03 <.0001 0.36 0.25 .141
Diagnostic
angiogram
0.05 0.07 .496 0.19 0.01 <.0001 124.25 0.01 <.0001 0.06 0.01 <.0001 0.05 0.07 .471
Elective 0.09 0.14 .511 1.18 0.01 <.0001 373.33 0.02 <.0001 0.84 0.01 <.0001 0.09 0.14 .503
LER volume/y
Q1: 0-11 0.25 0.17 .131 0.51 0.01 <.0001 71.72 0.00 <.0001 0.04 0.01 .004 0.25 0.17 .141
Q2: 12-71 0.08 0.20 .694 0.94 0.02 <.0001 169.11 0.03 <.0001 0.35 0.02 <.0001 0.08 0.20 .687
Q3: 72-248 0.25 0.21 .227 2.05 0.02 <.0001 90.09 0.04 <.0001 0.99 0.03 <.0001 0.25 0.21 .233
Small hospital 0.88 0.50 .084 0.65 0.05 <.0001 282.13 0.04 <.0001 0.54 0.06 <.0001 0.89 0.51 .081
Medium hospital 1.42 1.04 .173 0.55 0.10 <.0001 154.33 0.12 <.0001 1.82 0.11 <.0001 1.44 1.03 .167
Midwest 0.05 21.10 .998 111.21 2.41 <.0001 1553.02 1.62 <.0001 101.16 2.38 <.0001 0.54 21.13 .980
South 0.62 0.63 .333 10.92 0.08 <.0001 108.66 0.10 <.0001 9.04 0.09 <.0001 0.62 0.63 .331
West 1.59 3.10 .610 8.09 0.49 <.0001 289.80 0.30 <.0001 66.48 0.57 <.0001 1.58 3.10 .611
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RB, relative bias; SE, standard error; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRB: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
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Supplementary Table IV (online only). Missing at random: 5% missing
Variable
CCA RF MIV MI RWEE
RBa SE P RBa SE P RBa SE P RBa SE P RBa SE P
Age, year
Q2: 62-70 0.25 0.20 .220 0.30 0.02 <.0001 0.26 0.04 <.0001 0.44 0.02 <.0001 0.41 0.20 .047
Q3: 71-78 0.55 0.22 .016 1.39 0.03 <.0001 1.37 0.06 <.0001 1.46 0.03 <.0001 0.22 0.23 .339
Q4: >78 0.20 0.52 .704 3.77 0.07 <.0001 3.72 0.12 <.0001 2.91 0.07 <.0001 0.54 0.53 .314
Race
Black 0.36 0.06 <.0001 2.47 0.06 <.0001 1.79 0.06 <.0001 3.68 0.07 <.0001 0.19 0.06 .002
Hispanic 0.04 0.11 .737 2.30 0.12 <.0001 2.43 0.12 <.0001 0.76 0.12 <.0001 0.13 0.11 .261
Asian/PI 0.41 0.43 .344 1.26 0.44 .005 1.38 0.44 .003 8.84 0.45 <.0001 0.35 0.43 .428
Native
American
0.30 0.36 .408 2.15 0.36 <.0001 1.45 0.36 .0001 1.48 0.36 <.0001 0.26 0.37 .481
Other 1.67 0.79 .037 2.59 0.78 .001 3.44 0.79 <.0001 16.49 0.80 <.0001 0.28 0.82 .736
Female sex 0.00 0.21 .990 1.80 0.03 <.0001 464.78 1.57 <.0001 1.66 0.03 <.0001 0.17 0.22 .442
Income
Q1 0.10 0.31 .759 9.62 0.10 <.0001 198.42 0.05 <.0001 5.71 0.10 <.0001 0.79 0.32 .016
Q2 0.28 0.46 .553 4.14 0.08 <.0001 61.49 0.15 <.0001 2.92 0.08 <.0001 0.69 0.47 .147
Q3 2.85 1.64 .085 5.91 0.23 <.0001 307.24 0.43 <.0001 4.69 0.26 <.0001 1.66 1.69 .329
Insurance
Private 0.54 0.18 .004 0.90 0.02 <.0001 111.00 0.04 <.0001 0.68 0.02 <.0001 0.24 0.19 .206
Medicaid 1.29 0.38 .001 1.52 0.07 <.0001 247.32 0.06 <.0001 0.80 0.07 <.0001 0.32 0.39 .414
Uninsured 0.98 3.07 .750 0.43 0.42 .308 565.80 0.56 <.0001 10.55 0.45 <.0001 1.49 3.15 .637
Small
metropolitan
11.27 0.27 <.0001 4.43 0.06 <.0001 81.28 0.13 <.0001 3.17 0.06 <.0001 0.39 0.28 .163
Micropolitan 36.72 1.47 <.0001 26.92 0.31 <.0001 189.91 0.32 <.0001 13.31 0.31 <.0001 1.66 1.45 .256
Nonmetropolitan 111.04 6.37 <.0001 138.46 1.50 <.0001 38.81 2.11 <.0001 83.01 1.52 <.0001 10.11 6.53 .124
Congestive heart
failure
0.39 0.05 <.0001 0.11 0.01 <.0001 101.68 0.02 <.0001 0.03 0.01 <.0001 0.07 0.05 .182
Cardiac valve
disease
0.68 0.28 .017 0.93 0.03 <.0001 287.98 0.04 <.0001 0.60 0.03 <.0001 0.24 0.28 .390
Complicated
diabetes
0.21 0.06 <.0001 0.11 0.01 <.0001 63.77 0.02 <.0001 0.16 0.01 <.0001 0.06 0.05 .281
Hypertension 0.57 0.15 <.0001 1.26 0.02 <.0001 383.12 0.04 <.0001 0.83 0.02 <.0001 0.09 0.15 .529
Electrolyte
disorders
0.02 0.09 .811 0.04 0.01 .004 154.60 0.02 <.0001 0.00 0.01 .927 0.00 0.09 .988
Neurologic
disorder
0.58 0.11 <.0001 0.41 0.02 <.0001 32.09 0.01 <.0001 0.38 0.02 <.0001 0.16 0.12 .172
Paralysis 0.37 0.10 <.0001 0.27 0.01 <.0001 22.54 0.02 <.0001 0.20 0.01 <.0001 0.15 0.10 .140
Vascular disease 0.70 0.05 <.0001 0.23 0.01 <.0001 220.02 0.03 <.0001 0.23 0.01 <.0001 0.05 0.05 .254
Renal failure 1.59 0.23 <.0001 3.19 0.04 <.0001 529.98 0.05 <.0001 1.58 0.05 <.0001 0.20 0.23 .405
Weight loss 0.48 0.09 <.0001 0.22 0.01 <.0001 79.74 0.01 <.0001 0.15 0.01 <.0001 0.14 0.10 .160
Obesity 3.45 0.30 <.0001 1.23 0.04 <.0001 472.51 0.08 <.0001 0.60 0.04 <.0001 0.21 0.30 .484
Deﬁciency
anemia
0.58 0.09 <.0001 0.50 0.01 <.0001 151.00 0.04 <.0001 0.38 0.01 <.0001 0.11 0.09 .195
Diagnostic
angiogram
0.17 0.03 <.0001 0.02 0.00 <.0001 123.94 0.01 <.0001 0.00 0.00 .791 0.01 0.03 .746
Elective 0.08 0.05 .074 0.21 0.01 <.0001 373.61 0.01 <.0001 0.17 0.01 <.0001 0.02 0.05 .714
LER volume/y
Q1: 0-11 0.40 0.05 <.0001 0.06 0.01 <.0001 72.01 0.00 <.0001 0.02 0.01 .0041 0.01 0.05 .807
Q2: 12-71 0.17 0.07 .017 0.17 0.01 <.0001 167.99 0.04 <.0001 0.06 0.01 <.0001 0.04 0.07 .535
3: 72-248 0.07 0.08 .414 0.30 0.01 <.0001 88.40 0.03 <.0001 0.14 0.01 <.0001 0.03 0.08 .722
Small hospital 4.59 0.18 <.0001 0.25 0.02 <.0001 278.82 0.03 <.0001 0.20 0.02 <.0001 0.12 0.18 .518
Medium hospital 12.19 0.35 <.0001 1.00 0.04 <.0001 141.08 0.12 <.0001 0.35 0.04 <.0001 0.01 0.33 .982
Midwest 313.54 10.04 <.0001 41.98 1.26 <.0001 1358.75 1.94 <.0001 28.90 1.20 <.0001 7.54 9.70 .439
South 5.55 0.23 <.0001 3.12 0.04 <.0001 120.92 0.14 <.0001 2.51 0.04 <.0001 0.32 0.23 .155
West 2.24 0.85 .010 0.48 0.23 .043 251.48 0.23 <.0001 11.88 0.24 <.0001 4.82 0.86 <.0001
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RB, relative bias; SE, standard error; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRB: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
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Supplementary Table V (online only). Missing at random: 15% missing
Variable
CCA RF MIV MI RWEE
RBa SE P RBa SE P RBa SE P RBa SE P RBa SE P
Age, years
Q2: 62-70 0.69 0.36 .057 0.95 0.04 <.0001 0.86 0.05 <.0001 1.34 0.04 <.0001 0.11 0.38 .765
Q3: 71-78 2.91 0.46 <.0001 4.58 0.05 <.0001 4.28 0.08 <.0001 4.52 0.05 <.0001 0.30 0.49 .543
Q4: >78 4.01 0.83 <.0001 12.63 0.10 <.0001 11.54 0.19 <.0001 9.20 0.11 <.0001 0.95 0.91 .296
Race
Black 0.83 0.09 <.0001 8.59 0.10 <.0001 5.69 0.10 <.0001 11.93 0.10 <.0001 0.03 0.10 .774
Hispanic 0.43 0.25 .092 10.17 0.27 <.0001 8.68 0.27 <.0001 1.66 0.25 <.0001 0.04 0.27 .867
Asian/PI 0.38 0.82 .644 0.59 0.81 .470 5.09 0.83 <.0001 27.21 0.80 <.0001 0.60 0.84 .480
Native
American
0.77 0.64 .229 7.21 0.62 <.0001 4.44 0.64 <.0001 2.78 0.58 <.0001 1.47 0.69 .035
Other 3.94 1.48 .009 10.23 1.41 <.0001 10.73 1.49 <.0001 59.12 135 <.0001 2.06 1.62 .209
Female sex 1.05 0.38 .007 6.01 0.05 <.0001 465.52 1.02 <.0001 5.09 0.05 <.0001 0.52 0.41 .213
Income
Q1 3.06 0.52 <.0001 32.87 0.14 <.0001 194.45 0.08 <.0001 18.46 0.16 <.0001 0.56 0.55 .313
Q2 1.27 0.91 .166 15.02 0.13 <.0001 93.96 0.25 <.0001 9.42 0.14 <.0001 0.13 0.99 .897
Q3 15.25 3.23 <.0001 23.18 0.35 <.0001 346.26 0.81 <.0001 15.53 0.41 <.0001 0.54 3.40 .875
Insurance
Private 0.87 0.37 .020 3.06 0.04 <.0001 112.54 0.08 <.0001 2.23 0.04 <.0001 0.38 0.40 .349
Medicaid 5.77 0.71 <.0001 5.47 0.10 <.0001 250.23 0.10 <.0001 2.59 0.10 <.0001 0.96 0.77 .214
Uninsured 1.40 5.91 .813 1.29 0.70 .067 592.04 0.82 <.0001 33.52 0.76 <.0001 0.52 6.30 .935
Small
metropolitan
32.57 0.55 <.0001 15.29 0.09 <.0001 80.40 0.19 <.0001 10.14 0.10 <.0001 0.29 0.56 .603
Micropolitan 96.29 3.01 <.0001 91.92 0.55 <.0001 81.66 0.61 <.0001 43.51 0.53 <.0001 2.77 3.12 .377
Nonmetropolitan 275.35 13.80 <.0001 465.06 2.26 <.0001 508.08 3.57 <.0001 265.48 2.39 <.0001 20.36 15.08 .180
Congestive heart
failure
1.58 0.08 <.0001 0.38 0.01 <.0001 107.74 0.04 <.0001 0.09 0.01 <.0001 0.03 0.09 .752
Cardiac valve
disease
2.93 0.58 <.0001 3.07 0.05 <.0001 287.08 0.06 <.0001 1.76 0.05 <.0001 0.62 0.61 .312
Complicated
diabetes
1.01 0.11 <.0001 0.39 0.01 <.0001 63.00 0.04 <.0001 0.50 0.01 <.0001 0.09 0.12 .458
Hypertension 1.65 0.26 <.0001 4.28 0.03 <.0001 386.35 0.06 <.0001 2.64 0.04 <.0001 0.04 0.27 .872
Electrolyte
disorders
0.03 0.16 .871 0.12 0.02 <.0001 153.06 0.03 <.0001 0.01 0.02 .620 0.01 0.18 .963
Neurologic
disorder
1.49 0.17 <.0001 1.36 0.02 <.0001 32.04 0.03 <.0001 1.22 0.03 <.0001 0.09 0.19 .653
Paralysis 1.76 0.18 <.0001 0.98 0.02 <.0001 21.82 0.03 <.0001 0.67 0.03 <.0001 0.00 0.19 .981
Vascular disease 2.44 0.09 <.0001 0.79 0.01 <.0001 220.76 0.04 <.0001 0.71 0.01 <.0001 0.05 0.11 .668
Renal failure 7.36 0.48 <.0001 10.86 0.06 <.0001 532.35 0.08 <.0001 5.00 0.07 <.0001 0.94 0.52 .076
Weight loss 1.36 0.19 <.0001 0.75 0.02 <.0001 78.32 0.02 <.0001 0.50 0.02 <.0001 0.06 0.20 .768
Obesity 10.84 0.60 <.0001 3.97 0.06 <.0001 474.04 0.12 <.0001 1.58 0.06 <.0001 0.07 0.63 .911
Deﬁciency
anemia
1.70 0.19 <.0001 1.72 0.02 <.0001 149.04 0.07 <.0001 1.21 0.02 <.0001 0.18 0.20 .385
Diagnostic
angiogram
0.58 0.06 <.0001 0.07 0.01 <.0001 124.61 0.01 <.0001 0.02 0.01 <.0001 0.03 0.06 .649
Elective 0.05 0.10 .623 0.70 0.01 <.0001 373.20 0.02 <.0001 0.51 0.01 <.0001 0.17 0.10 .100
LER volume/y
Q1: 0-11 1.52 0.10 <.0001 0.27 0.01 <.0001 71.90 0.01 <.0001 0.02 0.01 .150 0.07 0.11 .516
Q2: 12-71 0.76 0.12 <.0001 0.67 0.02 <.0001 168.72 0.06 <.0001 0.06 0.02 .000 0.23 0.14 .095
Q3: 72-248 0.22 0.17 .196 1.19 0.02 <.0001 89.15 0.06 <.0001 0.63 0.02 <.0001 0.14 0.18 .443
Small hospital 13.91 0.37 <.0001 1.02 0.04 <.0001 280.27 0.05 <.0001 0.61 0.05 <.0001 0.05 0.38 .894
Medium hospital 35.69 0.72 <.0001 3.47 0.07 <.0001 119.10 0.23 <.0001 1.08 0.07 <.0001 0.52 0.71 .470
Midwest 789.50 18.28 <.0001 121.80 1.88 <.0001 956.38 3.43 <.0001 74.12 2.15 <.0001 52.77 18.81 .006
South 15.56 0.49 <.0001 10.23 0.06 <.0001 149.62 0.22 <.0001 8.30 0.05 <.0001 3.31 0.52 .0001
West 20.44 1.70 <.0001 3.021 0.45 <.0001 253.20 0.40 <.0001 35.79 0.42 <.0001 28.43 1.77 <.0001
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RB, relative bias; SE, standard error; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRB: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
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Supplementary Table VI (online only). Missing at random: 30% missing
Variable
CCA RF MIV MI RWEE
RBa SE P RBa SE P RBa SE P RBa SE P RBa SE P
Age, years
Q2: 62-70 2.12 0.52 <.0001 1.52 0.04 <.0001 1.41 0.08 <.0001 2.11 0.05 <.0001 1.28 0.57 .028
Q3: 71-78 5.07 0.60 <.0001 7.51 0.05 <.0001 7.21 0.09 <.0001 7.16 0.07 <.0001 0.77 0.68 .256
Q4: >78 9.24 1.33 <.0001 20.81 0.12 <.0001 19.59 0.21 <.0001 14.55 0.14 <.0001 4.31 1.54 .006
Race
Black 1.56 0.16 <.0001 14.87 0.17 <.0001 9.33 0.17 <.0001 19.88 0.15 <.0001 0.14 0.18 .440
Hispanic 0.99 0.32 .003 18.86 0.33 <.0001 13.82 0.34 <.0001 2.16 0.31 <.0001 0.15 0.36 .685
Asian/PI 0.72 1.23 .557 6.18 1.18 <.0001 7.31 1.24 <.0001 40.59 1.09 <.0001 1.70 1.26 .180
Native American 2.99 0.99 .003 13.76 0.96 <.0001 8.99 0.99 <.0001 5.01 0.76 <.0001 0.53 1.09 .624
Other 11.56 2.00 <.0001 24.81 1.90 <.0001 22.73 2.05 <.0001 92.72 1.63 <.0001 3.12 2.26 .172
Female sex 0.47 0.57 .413 9.72 0.06 <.0001 468.24 0.83 <.0001 7.89 0.07 <.0001 0.41 0.64 .525
Income
Q1 4.89 0.77 <.0001 54.06 0.18 <.0001 191.06 0.09 <.0001 29.69 0.21 <.0001 0.11 0.83 .893
Q2 2.02 1.25 .109 26.30 0.14 <.0001 122.96 0.34 <.0001 15.53 0.16 <.0001 0.43 1.39 .759
Q3 19.74 4.54 <.0001 41.92 0.48 <.0001 387.23 0.95 <.0001 25.27 0.54 <.0001 6.72 5.10 .191
Insurance
Private 1.95 0.51 <.001 5.06 0.04 <.0001 114.37 0.10 <.0001 3.59 0.05 <.0001 0.14 0.57 .805
Medicaid 7.98 0.95 <.0001 9.03 0.11 <.0001 253.09 0.13 <.0001 4.08 0.14 <.0001 0.07 1.10 .952
Uninsured 14.98 8.08 .067 1.91 0.80 .018 610.37 1.01 <.0001 52.01 1.01 <.0001 5.47 9.13 .551
Small
metropolitan
46.33 0.73 <.0001 25.84 0.11 <.0001 80.38 0.25 <.0001 16.60 0.13 <.0001 0.39 0.76 .613
Micropolitan 136.88 4.24 <.0001 151.58 0.56 <.0001 1.76 0.73 .018 71.04 0.73 <.0001 2.88 4.34 .508
Nonmetropolitan 378.96 17.86 <.0001 752.32 2.82 <.0001 915.44 3.34 <.0001 422.77 3.59 <.0001 44.32 19.27 .024
Congestive heart
failure
2.63 0.12 <.0001 0.65 0.01 <.0001 112.40 0.05 <.0001 0.20 0.01 <.0001 0.01 0.13 .936
Cardiac valve
disease
2.51 0.78 .002 5.01 0.06 <.0001 286.19 0.08 <.0001 2.66 0.07 <.0001 0.35 0.83 .674
Complicated
diabetes
2.25 0.15 <.0001 0.70 0.02 <.0001 62.63 0.05 <.0001 0.76 0.02 <.0001 0.26 0.16 .105
Hypertension 3.26 0.40 <.0001 6.80 0.04 <.0001 388.54 0.08 <.0001 4.08 0.05 <.0001 0.65 0.44 .144
Electrolyte
disorders
0.11 0.24 .639 0.17 0.02 <.0001 151.81 0.04 <.0001 0.03 0.03 .233 0.00 0.27 .986
Neurologic
disorder
2.55 0.27 <.0001 2.15 0.03 <.0001 32.04 0.02 <.0001 1.94 0.03 <.0001 0.44 0.29 .135
Paralysis 2.49 0.28 <.0001 1.65 0.02 <.0001 21.26 0.04 <.0001 1.10 0.03 <.0001 0.38 0.30 .202
Vascular disease 4.00 0.11 <.0001 1.28 0.01 <.0001 221.46 0.06 <.0001 1.08 0.01 <.0001 0.02 0.13 .887
Renal failure 11.64 0.71 <.0001 17.59 0.08 <.0001 534.45 0.09 <.0001 7.90 0.11 <.0001 0.79 0.79 .323
Weight loss 2.19 0.24 <.0001 1.13 0.02 <.0001 77.02 0.02 <.0001 0.73 0.03 <.0001 0.06 0.27 .811
Obesity 14.75 0.91 <.0001 6.71 0.06 <.0001 475.23 0.14 <.0001 2.59 0.08 <.0001 1.41 1.00 .164
Deﬁciency
anemia
2.55 0.23 <.0001 2.86 0.03 <.0001 148.43 0.07 <.0001 1.96 0.03 <.0001 0.15 0.25 .550
Diagnostic
angiogram
0.89 0.09 <.0001 0.16 0.01 <.0001 125.15 0.01 <.0001 0.01 0.01 .061 0.13 0.10 .166
Elective 0.31 0.15 .046 1.19 0.01 <.0001 372.74 0.02 <.0001 0.81 0.01 <.0001 0.03 0.17 .846
LER volume/y
Q1: 0-11 2.43 0.13 <.0001 0.50 0.01 <.0001 71.77 0.01 <.0001 0.01 0.01 .666 0.14 0.14 .325
Q2: 12-71 1.41 0.18 <.0001 1.08 0.02 <.0001 169.39 0.07 <.0001 0.14 0.02 <.0001 0.42 0.20 .042
Q3: 72-248 0.84 0.19 <.0001 2.05 0.02 <.0001 90.03 0.06 <.0001 1.12 0.03 <.0001 0.52 0.21 .014
Small hospital 20.35 0.48 <.0001 1.63 0.05 <.0001 281.88 0.08 <.0001 0.79 0.05 <.0001 0.15 0.53 .770
Medium hospital 52.97 0.79 <.0001 4.94 0.09 <.0001 104.88 0.26 <.0001 1.08 0.10 <.0001 0.34 0.87 .697
Midwest 1103.13 29.82 <.0001 165.59 2.02 <.0001 676.05 3.98 <.0001 118.39 2.57 <.0001 17.50 32.38 .590
South 25.81 0.69 <.0001 15.78 0.06 <.0001 164.26 0.24 <.0001 12.77 0.08 <.0001 3.02 0.76 <.001
West 25.70 2.51 <.0001 6.54 0.53 <.0001 258.14 0.44 <.0001 54.16 0.55 <.0001 37.14 2.73 <.0001
CCA, Complete case analysis; LER, lower extremity revascularization; MI, multiple imputation; MIV, missing indicator variable; PI, Paciﬁc Islander;
Q, quartile; RB, relative bias; SE, standard error; RF, replacement with observed frequencies; RWEE, reweighted estimating equations.
aRB: 0%-5% ¼ negligible, 5%-10% ¼ minimal, 10%-20% ¼ moderate, 20%-30% ¼ heavy, >30% ¼ severe.
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